Back to companies

PORTFOLIO

Noscendo

Noscendo offers a completely new way of identifying pathogens causing diseases in patients. Through a paradigm shift based on proprietary algorithms and software harnessing next-generation sequencing data, Noscendo identifies pathogens from patient samples. This supports physicians to make the right decisions in difficult situations and in a relevant time frame.

Milestones

Founded: 2017 Invested: 2020

Leadership Team

Andreas Käpplein

HQ

Duisburg, Germany

Earlybird Lead

OUR PORTFOLIO

OUR PORTFOLIO

SIMILAR COMPANIES

SIMILAR COMPANIES

SIMILAR COMPANIES

Meet the companies we’ve backed on their way to creating groundbreaking change.

Meet the companies we’ve backed on their way to creating groundbreaking change.

WE INVEST BECAUSE
WE BELIEVE

Got an idea that could change the world? If you're an early-stage founder with big ambitions, we'd love to hear from you.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.

Berlin

Münzstraße 23

10178 Berlin

Cologne

Harry-Blum-Platz 2,

D-50678 Cologne

© 2025 Earlybird Venture Capital. All rights reserved.